Leading Independent Research and Consulting Company Focused on Peripheral Artery Disease (PAD) and Critical Limb Ischemia (CLI)
Consulting Expertise
Diseases
- Peripheral Artery Disease PAD
- Critical Limb Ischemia CLI
- Intermittent Claudication IC
- Asymptomatic Disease
- Acute Limb Ischemia ALI
- Diabetic Foot Ulcer DFU
- Peripheral Neuropathy
- Buerger’s Disease
Therapies
- Chronic Total Occlusions
- Thrombus Removal Thrombolytics
- Anticoagulants
- Antiplatelets
- Balloon Angioplasty
- Atherectomy
- Stents
- Peripheral Bypass
- Angiogenesis/Biotechnology
- Stem Cells
Economics
- Macro Costs
- Cost-Effectiveness
- Outcomes
- Competitive Product Analysis
- Technology Assessment
- Coding
- Reimbursement
Knowledge & Awareness
- Physician
- Consumer
Geographic Expertise
- United States
- Europe
- Canada
- Middle East
- Latin America
- China
- India
- Asia
THE SAGE GROUP Research:
The prevalence of peripheral artery disease (PAD) in the U.S. is much higher than the commonly cited figures of 8-12 million.
According to THE SAGE GROUP, 20 million people in the U.S. had PAD in 2015.